A Gram Research analysis of a 2026 randomized controlled trial found that combining prebiotic and short-chain fatty acid supplements significantly reduced constipation in 72 Parkinson’s disease patients over 6 months, with the combination producing the most pronounced improvements in bowel regularity, stool consistency, and quality of life. The prebiotic alone also showed benefits, while short-chain fatty acids alone were less effective.
Constipation affects up to 90% of people with Parkinson’s disease and can appear years before movement problems start. Researchers tested whether special supplements called prebiotics and short-chain fatty acids could help. In a 6-month study of 72 Parkinson’s patients, those who took a combination of both supplements experienced the most improvement in constipation symptoms and quality of life. The findings suggest that targeting gut health through specific dietary supplements may offer a safe way to relieve this common and distressing symptom.
Key Statistics
A 2026 randomized controlled trial of 72 Parkinson’s disease patients found that combined prebiotic and short-chain fatty acid supplementation significantly reduced constipation severity and improved stool consistency and defecation frequency over 6 months.
According to research reviewed by Gram, the prebiotic 2-fucosyllactose alone significantly reduced constipation in Parkinson’s patients, though the combination with short-chain fatty acids produced more sustained and pronounced benefits across multiple measures.
In a 6-month study of 72 Parkinson’s disease patients, the combination supplement group reported meaningful improvements in constipation-related quality of life, with benefits remaining consistent throughout the entire study period.
The Quick Take
- What they studied: Whether special supplements that feed good gut bacteria and contain beneficial fatty acids could reduce constipation in people with Parkinson’s disease
- Who participated: 72 people diagnosed with Parkinson’s disease who were experiencing constipation. They were divided into three groups and received different supplements for 6 months.
- Key finding: The combination of both supplements (prebiotic 2-fucosyllactose plus short-chain fatty acids) worked best, significantly reducing constipation severity and improving bowel regularity and stool consistency
- What it means for you: If you have Parkinson’s disease and struggle with constipation, these supplements may help improve your symptoms and daily quality of life. However, talk to your doctor before starting any new supplements, and more research is needed on long-term safety and effectiveness.
The Research Details
This was a randomized controlled trial, which is one of the strongest types of medical research. Researchers randomly assigned 72 Parkinson’s patients into three groups: one received short-chain fatty acids (SCFA), another received a prebiotic called 2-fucosyllactose (2-FL), and the third group received both supplements combined. Nobody knew which group they were in—not the patients or the researchers measuring results—which helps prevent bias.
Participants took their assigned supplements for 6 months while researchers tracked their constipation using three different measurement tools: the Cleveland Clinic Constipation Score (which rates constipation severity), the Bristol Stool Scale (which describes stool type), and a quality-of-life questionnaire specifically about constipation. Researchers also checked physical activity levels and did routine neurological exams.
This design is important because it allows researchers to see which supplement actually caused the improvement, rather than just observing what happens naturally over time.
The randomized, double-blind design is crucial because constipation is subjective—how people feel about their symptoms can be influenced by expectations. By keeping both patients and researchers blinded to which supplement each person received, the study avoids this bias. Testing three different approaches (SCFA alone, prebiotic alone, and combination) helps identify which strategy works best.
This study has several strengths: it’s a randomized controlled trial (the gold standard for testing treatments), it used multiple validated measurement tools rather than just asking patients how they feel, it had a reasonable sample size of 72 participants, and it lasted 6 months (long enough to see real changes). The study was registered with a clinical trials database, which increases transparency. However, the study is relatively small and only followed people for 6 months, so longer-term effects remain unknown.
What the Results Show
The combination of 2-fucosyllactose and short-chain fatty acids produced the strongest results. Participants in this group experienced significant reductions in constipation severity, with improvements in how often they had bowel movements and the consistency of their stool. These improvements were sustained throughout the 6-month study period.
The prebiotic 2-fucosyllactose alone also showed significant benefits for reducing constipation, though not quite as strong as the combination. Short-chain fatty acids alone showed less dramatic improvements compared to the other two groups.
Beyond just the physical symptoms, participants in the combination group reported meaningful improvements in their quality of life related to constipation. This is important because constipation doesn’t just affect the body—it can cause embarrassment, anxiety, and reduce daily activities.
Interestingly, physical activity levels didn’t change during the study and didn’t influence the constipation improvements, suggesting the supplements themselves were responsible for the benefits rather than lifestyle changes.
The study found that the combination approach provided the most consistent and sustained benefits over the entire 6-month period, meaning people didn’t just improve initially and then plateau. This consistency is important for real-world use. The improvements were measured across multiple different assessment tools, which strengthens confidence in the results. The fact that physical activity remained unchanged but constipation still improved suggests these supplements work through their effect on gut bacteria and digestive function, not through increased movement.
This research builds on earlier observations that people with Parkinson’s disease have imbalanced gut bacteria and reduced production of short-chain fatty acids. Previous studies suggested this gut imbalance might contribute to Parkinson’s symptoms, but few had tested whether fixing it could help. This study is among the first to directly test whether supplementing these specific gut-health compounds improves constipation in Parkinson’s patients. The findings align with growing evidence that gut health plays a role in Parkinson’s disease.
The study only lasted 6 months, so we don’t know if benefits continue longer or if people need to keep taking supplements indefinitely. The sample size of 72 is moderate—larger studies would provide more confidence. The study didn’t track whether these supplements might slow Parkinson’s disease progression itself, only whether they relieved constipation. We also don’t have detailed information about whether certain types of Parkinson’s patients benefit more than others. Finally, the study was retrospectively registered (registered after it started), which is less ideal than pre-registration.
The Bottom Line
If you have Parkinson’s disease and constipation, discuss with your neurologist or gastroenterologist whether a combination of prebiotic and short-chain fatty acid supplements might help. The evidence from this study is moderately strong (a well-designed trial of 72 people), but more research is needed. These supplements appear safe based on this 6-month study, but long-term safety data is limited. Don’t stop other constipation treatments without medical guidance.
This research is most relevant for people with Parkinson’s disease experiencing constipation, their caregivers, and their healthcare providers. It may also interest researchers studying Parkinson’s disease and gut health. People without Parkinson’s shouldn’t assume these supplements will help their constipation without consulting their doctor, as the benefits were demonstrated specifically in this population.
Based on this study, participants saw meaningful improvements within 6 months. Some benefits may appear earlier, but the study measured outcomes at the 6-month mark. Realistic expectations: give the supplements at least several weeks to work, as changes in gut bacteria take time. Don’t expect overnight results.
Frequently Asked Questions
Can prebiotics and short-chain fatty acids help with Parkinson’s constipation?
Research shows that combining prebiotic 2-fucosyllactose with short-chain fatty acids significantly reduced constipation in 72 Parkinson’s patients over 6 months, improving bowel regularity and quality of life. The prebiotic alone also helped, though the combination worked best.
How long does it take for these supplements to work for constipation?
The 6-month study showed meaningful improvements by the end of the period, but changes in gut bacteria take time. Allow several weeks before expecting noticeable benefits. Talk to your doctor about realistic timelines for your situation.
Is constipation common in Parkinson’s disease?
Yes, constipation affects up to 90% of people with Parkinson’s disease and often appears years before movement problems develop. It’s linked to changes in gut bacteria and reduced production of beneficial short-chain fatty acids.
Are prebiotic and short-chain fatty acid supplements safe for Parkinson’s patients?
This 6-month study found no safety concerns, but long-term safety data is limited. Always consult your neurologist before starting new supplements, especially if you take other medications for Parkinson’s or other conditions.
Can these supplements slow Parkinson’s disease progression?
This study only tested whether supplements relieved constipation, not whether they slow disease progression. Researchers noted that future studies should investigate potential disease-modifying effects, but that hasn’t been proven yet.
Want to Apply This Research?
- Track daily bowel movements and stool consistency using the Bristol Stool Scale (types 1-7, with 3-4 being ideal). Log this weekly in your app along with any constipation-related discomfort on a 0-10 scale.
- Start taking the recommended prebiotic and short-chain fatty acid supplements as directed by your doctor. Set daily reminders in your app to take supplements at the same time each day to build consistency.
- Use your app to track constipation symptoms weekly for the first month, then bi-weekly for months 2-6. Compare your baseline scores (before starting supplements) to your scores at 4 weeks, 8 weeks, and 6 months to see if you’re improving. Share these trends with your doctor at follow-up appointments.
This research describes findings from a single 6-month clinical trial. While the results are promising, they should not replace medical advice from your healthcare provider. Do not start, stop, or change any supplements or medications without consulting your doctor, especially if you have Parkinson’s disease or take other medications. This study tested specific supplements in a specific population; results may not apply to everyone. Long-term safety and effectiveness beyond 6 months have not been established. Always work with your neurologist or gastroenterologist before trying new treatments for constipation.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.